Latest period
$47.00K
YoY change
-43.5%
5Y CAGR
-25.0%
Peak year (2022)
$279.00K
Cumulative CapEx
$835.06K
CapEx history chart for Equillium (EQ) from 2017 to 2025
Latest: $48.00K
CapEx growth chart for Equillium (EQ) from 2017 to 2025
Latest: -43.5%
CapEx history table for Equillium (EQ) from 2017 to 2025
| 2025 | $48.00K | -43.5% | −$37.00K | ||
| 2024 | $85.00K | +70.0% | +$35.00K | ||
| 2023 | $50.00K | -82.1% | −$229.00K | ||
| 2022 | $279.00K | +389.5% | +$222.00K | ||
| 2021 | $57.00K | -71.8% | −$145.00K | ||
| 2020 | $202.00K | +173.0% | +$128.00K | ||
| 2019 | $74.00K | +112.3% | +$39.14K | ||
| 2018 | $34.86K | +1485.2% | +$32.66K | ||
| 2017 | $2.20K | — | — |
- 2025$48.00K-43.5%
- 2024$85.00K+70.0%
- 2023$50.00K-82.1%
- 2022$279.00K+389.5%
- 2021$57.00K-71.8%
- 2020$202.00K+173.0%
- 2019$74.00K+112.3%
- 2018$34.86K+1485.2%
- 2017$2.20K—
CapEx values are taken from Equillium's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Equillium (EQ)
According to Equillium's latest reported financial statements, the company's current CapEx (TTM) is $47.00K. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Equillium (EQ) most recent annual CapEx stands at $48.00K (2025) – plunged 43.5% year-over-year.
Equillium CapEx has contracted on net over the period, with a -25.0% compound annual growth rate over 2020–2025 (5 years).
Equillium CapEx plunged from $279.00K in 2022 to $48.00K in 2025, a 82.8% drawdown.
$279.00K stands as the all-time-high annual CapEx, posted in 2022, against a low of $2.20K during 2017.
Equillium Capital Expenditures by Year
Equillium Capital Expenditures 2025: $48.00K
In 2025, Equillium reported CapEx of $48.00K, plunged 43.5% below 2024.
Equillium Capital Expenditures 2024: $85.00K
Equillium CapEx in 2024 was $85.00K, surged 70.0% from 2023.
Equillium Capital Expenditures 2023: $50.00K
2023's CapEx for Equillium came in at $50.00K, plunged 82.1% below 2022.
Equillium Capital Expenditures 2022: $279.00K
Equillium posted CapEx of $279.00K in 2022, surged 389.5% from 2021. This figure represents the highest annual value in the available history.
Equillium Capital Expenditures 2021: $57.00K
Equillium CapEx in 2021 was $57.00K.
See more financial history for Equillium (EQ).
Sector peers by CapEx
Healthcare peers of Equillium (EQ), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Equillium (EQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation